Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Preferred Shares (2016 - 2025)

Palisade Bio (PALI) has disclosed Preferred Shares for 10 consecutive years, with $2000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Preferred Shares changed 0.0% to $2000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2000.0, a 0.0% change, with the full-year FY2024 number at $2000.0, changed 0.0% from a year prior.
  • Preferred Shares was $2000.0 for Q3 2025 at Palisade Bio, roughly flat from $2000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $2000.0 in Q1 2021 to a low of $2000.0 in Q1 2021.
  • A 5-year average of $2000.0 and a median of $2000.0 in 2021 define the central range for Preferred Shares.
  • Biggest YoY gain for Preferred Shares was 0.0% in 2021; the steepest drop was 0.0% in 2021.
  • Palisade Bio's Preferred Shares stood at $2000.0 in 2021, then changed by 0.0% to $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Preferred Shares are $2000.0 (Q3 2025), $2000.0 (Q2 2025), and $2000.0 (Q1 2025).